Objective. Behçet's disease (BD) is a rare multisystem disorder characterized by vasculitis. At present, there are no laboratory markers that correlate well with the clinical activity in BD. This has led to the development of an instrument (BD Current Activity Form) to measure activity. Scoring is based on the history of new clinical features present over the preceding 4 weeks prior to assessment. Standardized questions were developed for all parts of the form. The face validity of the proforma was determined following worldwide collaboration with physicians and ophthalmologists managing patients with BD. The aim of this study was to evaluate the interobserver reliability of this form.
Behçet's disease (BD) is a rare multisystem disorder available to assess disease activity [ The Iranian Behçet's Disease Dynamic Measure (IBDDAM ) [4] and a characterized by vasculitis. The classification of this European scheme initially developed in the UK ]. condition depends on the presence of clinical features Interobserver and intra-observer agreement between two as defined by the International Study Group (ISG) on clinicians using both forms were assessed in 13 patients Behçet's Disease [1] . The availability of an international, with BD as defined by the ISG criteria. Reliability standardized, reliable measure of disease activity is of depends not only on the patient's accurate recall of prime importance in monitoring the natural history and symptoms, but also on the clinician's interpretation of effects of therapeutic intervention in BD [2] . At present, them. This study suggested that agreement between there are no laboratory markers that correlate well with clinicians in scoring of clinical features was greater when clinical activity in BD. This has led to the development the standard period was 28 days, as in the European of a standardized proforma [Behçet's Disease Current form, compared with the Iranian form in which a Activity Form (BDCAF )] to assess disease activity variable time period is taken [3] . Although there was which is based on history of clinical features.
greater variability in scoring when the Iranian form was Previous work [3] compared two schemes that were used, the opinion of the clinicians was that both forms had good aspects and that an internationally accepted As a result of this study, a prototype form was developed incorporating aspects of both forms. This and instructions. This study was conducted over 1 day. All subjects were randomly allocated to the assessors was circulated to all members of the International Scientific Committee for comments. A workshop was
(1-5). All subjects were independently questioned and examined on the same day by all observers. Scoring was held in Leeds, UK, in 1994 to arrive at a consensus view about the contents of the activity form (face based on the patient's response to a series of standard questions for each organ system subscale comprising the validity) with emphasis on the need for clarity and consistency for potential use by clinicians worldwide. general disease activity form. All assessment forms were coded to prevent patient identification. At the end of The inclusion of laboratory parameters within the activity form was raised by various members of the each assessment, any qualitative difficulties in completing the forms were documented by the assessors. International Scientific Committee on Behçet's Disease. Although it was agreed that inclusion of erythrocyte Statistical analysis sedimentation rate ( ESR) and C-reactive protein (CRP) measurements would not add significantly to overall
The test-retest reliability of the scoring was assessed with respect to two properties: bias and agreement. The measurement of disease activity [5] , it was appreciated that where disease appeared to be clinically inactive, a presence of bias relates to the systematic deviation between observers in their scoring patterns, while the raised ESR or CRP might prompt further investigation. There was general agreement that standardized queslevel of agreement reflects the extent of random differences in scoring between the five observers. A high level tions should be developed for each organ system which could be readily translated for international use. The of reliability for the form constitutes a high level of agreement in the score for each organ system in the interobserver reliability of this new instrument developed from these discussions is presented here. absence of bias. to incorporate the relative seriousness of the different Instrument amounts of disagreement. The weighted kappa statistic can be calculated between pairs of clinicians; however, The BDCAF scores oral and genital ulceration, skin, the calculation of an overall weighted kappa value for joint and gastrointestinal involvement, presence of all five clinicians is not possible using this method. fatigue and headache according to the duration of Therefore, an overall kappa value for all five clinicians symptoms. The presence and type of large-vessel and was estimated by using the intraclass correlation coefficentral nervous system (CNS) involvement are docucient ( ICC ). mented. Eye activity was deemed present if there was a
The possibility of bias was also considered separately history of blurring of vision or if the eye was painful or for each organ system. The proportions of patients who red. All patients were examined by an ophthalmologist were scored as having involvement within each of the who completed the Behçet's Oculopathy Index. This dichotomous variables (eye, CNS and major vessel index was subject to a separate reproducibility evaluinvolvement) were compared using the x2 statistic (values ation in a subsequent study. In addition, patients were >3.84 indicating bias). For the organ systems that were asked to rate on a seven-point scale how active they felt rated using a five-point scale, the distribution of scoring their BD disease had been over the preceding 4 weeks was compared using the ANOVA method to detect any and on the day of assessment. The clinicians also comclinician consistently scoring higher or lower for an pleted a seven-rating scale to assess their opinion of organ system. The strength of any bias is given as a P overall activity. Only new symptoms over the preceding value. Finally, comparison of the clinicians' and patients' 4 weeks that the clinicians felt were due to BD were scored. Standardized questions were developed for all perception of overall disease activity was calculated showed very good agreement and no systematic bias between the remaining four assessors (ICC = 0.82; using the ICC. F = 0.087, P = 0.967). Table 3 shows the kappa values between the assessors' Results rating of the presence of eye activity. The overall kappa is 0.77, implying good agreement between the assessors Of 20 patients initially recruited, one became ill during the study and was unable to complete it. Data on the about the presence of activity. There was significant bias in the assessment of eye disease by Assessor 5 who remaining 19 patients are presented. Table 2 shows the bias and level of agreement between assessors when consistently rated more patients as having active eye disease when compared to the other four assessors. rating oral and genital ulceration, skin, joint and gastrointestinal involvement. Level of agreement is indicated Table 4 shows the level of agreement between the assessors in identifying active CNS involvement. The by the ICC. Overall, the ICCs are >0.60 for oral and genital ulceration, skin, joint involvement and the presoverall kappa is 0.61, indicating good agreement between the assessors about the presence of new nervous ence of headache, implying good agreement between assessors' rating of these symptoms. There was, however, system involvement. Assessment of bias showed a complicated relationship between assessors, with Assessors poor agreement for rating the presence of bloody diarrhoea. There was generally little bias between the 4 and 5 consistently finding more new nervous system activity than Assessors 1 and 3. There was considerable assessors apart from rating fatigue, where a significant bias was identified. This bias related to Assessor 3 who difficulty in categorizing the type of nervous system involvement. In eight patients who were deemed to have consistently rated this symptom lower than the other four assessors. Repeat analysis omitting this assessor new neurological involvement by one or more of the The problem of scoring new disease activity and disaggregating it from established damage and resultant used in the development of the BD activity proforma. As with these indices, measurement of BD activity has functional loss has exercised clinicians treating several multisystem diseases. Collaborative efforts have led to to encompass several organ systems. Disease 'severity', disease 'activity' and established damage should be the establishment of several systemic lupus erythematosus indices [6] [7] [8] . A similar approach has been considered separately. The scoring system must (a) adequately span the range between no activity and in rating the presence and duration of bloody diarrhoea suggests that it is not often easy to determine from maximum activity in each system, (b) be free of systematic bias between different clinicians, (c) be valid, (d ) be history alone whether this symptom relates to mucosal inflammation or is merely the result of a combination reproducible, (e) be comprehensive enough to incorporate geographical variability in clinical features [9] and of other conditions such as drug-related diarrhoea (e.g. colchicine) and bleeding haemorrhoids. This item was (f ) be simple enough to use in routine clinical practice.
Several instruments have been developed worldwide included in the BD proforma as a result of its use in a proforma for measuring clinical activity in inflammatory incorporating broadly similar organ system subscales. In some instruments, the measurement of disease activity bowel disease by the gastroenterology service. Patients in whom mucosal inflammation was suspected were relies solely on clinical features [2], while others include laboratory investigations, and changes in body weight referred to the gastroenterology service for further investigation and advice. and temperature. Although changes in body weight and temperature may indicate systemic activity, we have
The need for surrogate indicators of activity also applies to large-vessel and nervous system involvement. found them neither specific nor sensitive enough as markers for disease activity. Similarly, haemoglobin and Currently, MRI does not have a role in the monitoring of neurological disease activity as MRI lesions can be ESR do not correlate well with activity [5] .
In common with many other rheumatic diseases, the identified in patients with [10] and without [11, 12] clinical evidence of CNS involvement. Therefore, assessclinical features in BD vary considerably over time. In order to document this variation, new clinical features ment of CNS involvement in BD is based on clinical features. As CNS involvement may be a solitary event present over the preceding 28 days are scored using the BDCAF. This represents a compromise between (e.g. stroke) or relapsing (e.g. aseptic meningitis), it seems appropriate to score activity based on the site of assessing disease activity based on (a) clinical features on the day of assessment, which may be unrepresentative lesion (e.g. meningeal, hemispheric, basal ganglia, brain stem and spinal cord), bearing in mind that the pathoof overall disease activity and (b) clinical features present over a longer time period, as in the IBDDAM, physiology of CNS involvement remains unclear. This system would have merit as the location of presumed which reduces reliability in terms of accurate recall of symptoms by the patient. pathology could be determined by clinical features and radiological imaging. Currently, there is not sufficient The disease activity rating for oral and genital ulceration, and skin lesions using the BDCAF relies solely knowledge of the natural history of lesions at various sites to enable the severity of the type of involvement on the duration of symptoms and does not take into account the size or number of lesions present, which to be graded and, therefore, the BDCAF aims to record and categorize neurological events during the course of might also reflect activity. Unfortunately, although documentation of the latter may be more representative the disease. This study shows that while there was good agreement in terms of identifying new CNS involvement, of activity, its reliability is likely to be poor because of the difficulty for patients in recalling these symptoms there remained disagreement between the assessors on the probable location of lesions based on clinical history accurately (the number and size of ulcers/skin lesions). There was good agreement between assessors in the and examination. From a practical perspective, further opinion is sought from a neurologist when neurological scoring of oral and genital ulceration, and joint and skin manifestations using duration of symptoms alone. symptoms or signs are present (particularly if they are new), which may then require the CNS score to be Although duration alone may not encapsulate all the features of activity in these organ systems, this scoring amended. Although the skin pathergy reaction is highly specific appears to be relatively simple to use, reliable and free of bias. Fatigue is a common problem in patients with for BD, there is considerable variation in the rate of positivity in patients from different geographical areas, BD, although it is not known how it correlates with the other clinical features. Assessor 3 consistently rated the which limits its clinical usefulness. A positive pathergy reaction is common in patients from Iran, Turkey and fatigue symptoms lower than the other four assessors. The results from this study confirm that clinicians may Japan, but rare in those from the UK, the USA and France. Although this test has diagnostic importance, differ in whether they attribute fatigue to BD or to other conditions that may co-exist, such as fibromyalgia.
there is no evidence to suggest that its presence correlates with disease activity. The main difficulties with using Although the presence of fibromyalgia was not specifically identified in this study, further studies are needed this test as a measure of disease activity are the lack of consensus on the procedure (e.g. the optimal number of to quantify fibromyalgic symptoms in patients with BD.
Surrogate indicators are required for lesions that are needle pricks needed [13] ) and the practicalities, in a routine out-patient clinic, of grading the reaction 2 days less visible. Routine direct scoring of gastrointestinal (GI ) activity is difficult. The scale to assess GI tract after administration. For these reasons, it was not included as part of the disease activity assessment in the activity is based on two questions designed to identify upper and lower GI tract inflammation. The scoring BDCAF. The reliability of scores obtained for the patient and represents a compromise between ease of monitoring activity and the accuracy with which the answers to the physician perception of overall activity was only moderate and associated with bias. While an overall perception questions reflect inflammation. The lack of agreement
